1. Home
  2. NHS vs PROF Comparison

NHS vs PROF Comparison

Compare NHS & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuberger Berman High Yield Strategies Fund

NHS

Neuberger Berman High Yield Strategies Fund

SELL

Current Price

$5.33

Market Cap

251.6M

Sector

Finance

ML Signal

SELL

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$5.93

Market Cap

248.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NHS
PROF
Founded
2003
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
251.6M
248.8M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
NHS
PROF
Price
$5.33
$5.93
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $11.14
AVG Volume (30 Days)
★ 322.6K
269.4K
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 13.44%
N/A
EPS Growth
N/A
★ 25.89
EPS
★ N/A
N/A
Revenue
N/A
★ $16,098,000.00
Revenue This Year
N/A
$71.10
Revenue Next Year
N/A
$58.54
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 50.73
52 Week Low
$5.26
$4.91
52 Week High
$7.75
$8.95

Technical Indicators

Market Signals
Indicator
NHS
PROF
Relative Strength Index (RSI) 25.88 43.80
Support Level N/A $5.74
Resistance Level $6.12 $6.23
Average True Range (ATR) 0.07 0.43
MACD 0.01 0.01
Stochastic Oscillator 20.41 15.14

Price Performance

Historical Comparison
NHS
PROF

About NHS Neuberger Berman High Yield Strategies Fund

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Share on Social Networks: